Skip to main content
Subscribe
Sign in
Menu
Membership
Events
Knowledge Center
About
Register
Search
Sign In
Sign In
Register
Subscribe
Stephen Taub
Latest Articles
Affinity, Janus Henderson Outpace Biopharma Peers in Tough Month
Stephen Taub
August 13, 2026
For Members Only
Why Greenlight Is Betting on These Five Stocks
Stephen Taub
August 12, 2026
For Members Only
Maverick Keeps Winning Even as Chip Stocks Crumble
Stephen Taub
August 11, 2026
For Members Only
Third Point Hit by Momentum Reversal, Posts July Decline
Stephen Taub
August 10, 2026
For Members Only
Light Street Stung by July Tech Rout, Still Tops Broader Market
Stephen Taub
August 6, 2026
For Members Only
Biotech IPO Fever Shows No Signs of Breaking
Stephen Taub
August 5, 2026
D.E. Shaw’s Latest Offering
Stephen Taub
August 4, 2026
For Members Only
Greenlight Gains 5 Percent in July, But Clues to Rally Remain Scarce
Stephen Taub
August 3, 2026
Hedge Funds Back Record Number of Billion-Dollar VC Funding Rounds
Stephen Taub
July 30, 2026
For Members Only
RA Capital’s SPAC Finds Partner
Stephen Taub
July 29, 2026
For Members Only
Haidar Overhauls Portfolio as Losses Mount
Stephen Taub
July 28, 2026
For Members Only
Seligman Ventures Makes Ninth Investment Since February
Stephen Taub
July 27, 2026
For Members Only
After a Remarkable Run, Concentration Cuts Both Ways
Stephen Taub
July 23, 2026
For Members Only
Perceptive’s SPAC Finally Completes Merger
Stephen Taub
July 22, 2026
For Members Only
CTAs Suffer June Setback as Commodity Trends Unravel
Stephen Taub
July 21, 2026
For Members Only
Hedgies Eye Three Biopharma IPOs
Stephen Taub
July 20, 2026
For Members Only
RA Capital Launches Fourth SPAC as Private Investment Pipeline Continues to Grow
Stephen Taub
July 16, 2026
For Members Only
Skye Global’s Amazon Problem
Stephen Taub
July 15, 2026
More Articles